Lembas
Sheffield
About Lembas
Lembas is a foodtech startup that has developed "GLP-1 Edge," a patent-pending peptide ingredient designed to naturally boost the GLP-1 hormone, which helps regulate appetite and metabolism for weight management. Using AI-driven discovery and licensed technology from Tel Aviv University, Lembas offers this peptide powder as a business-to-business ingredient for food and supplement brands, providing a science-backed, non-pharmaceutical alternative to weight loss drugs with no reported side effects
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $3.6M
- Funding stage: Seed
- Last round: Pre-Seed (Jun 2025)
- Website: hellolembas.com
- Phone: [email protected]
Industries & Categories
Food and Beverage
Social Profiles
Canonical: https://fsome.com/organization/lembas-83557 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.